Fig. 5.

Symptom load and patient reported health outcome 6 weeks, 3, 6, and 12 months post-acute COVID: a) Cumulative median SGRQ-Score develops divergently over 12 months for different disease severity groups. Median total SGRQ is higher after HFO, IMV and ECMO treatment initially and decreases until month 12, whereas for LFO, NOH and NOO it remains constant over time of follow-up over 12 months. b) Cumulative symptom load for most frequently reported symptoms (as %) during follow up. Fatigue and respiratory symptoms score highest during follow up over 12 months. The proportion of patients reporting fatigue, pulmonary- and neurocognitive sequelae in our cohort remains high 12 months post-acute COVID-19.